Impact of N-acetylcysteine on antitumor activity of doxorubicin and landomycin A in NK/Ly lymphoma-bearing mice

N-acetylcysteine (NAC) is a dietary supplement demonstrating antioxidant and liver protecting effects that is widely used in clinics. NAC is considered to possess potential therapeutic activity for health disorders characterized by generation of free oxygen radicals, as well as potential for decreas...

Full description

Bibliographic Details
Main Authors: Yu. S. Kozak, R. R. Panchuk, N. R. Skorokhyd, L. V. Lehka, R. S. Stoika
Format: Article
Language:English
Published: National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry 2018-04-01
Series:The Ukrainian Biochemical Journal
Subjects:
Online Access:http://ukrbiochemjournal.org/wp-content/uploads/2018/03/Kozak_2_18.pdf
_version_ 1797422275339747328
author Yu. S. Kozak
R. R. Panchuk
N. R. Skorokhyd
L. V. Lehka
R. S. Stoika
author_facet Yu. S. Kozak
R. R. Panchuk
N. R. Skorokhyd
L. V. Lehka
R. S. Stoika
author_sort Yu. S. Kozak
collection DOAJ
description N-acetylcysteine (NAC) is a dietary supplement demonstrating antioxidant and liver protecting effects that is widely used in clinics. NAC is considered to possess potential therapeutic activity for health disorders characterized by generation of free oxygen radicals, as well as potential for decreasing negative side effects of various drugs. However, the mechanisms of such tissue-protective actions of NAC remain poorly understood. The main aim of this work was to study therapeutic effects of NAC applied together with the “gold standard” of chemotherapy doxorubicin (Dx) or the novel experimental drug landomycin A (LA) to mice bearing NK/Ly lymphoma. It was revealed that NAC significantly decreased the nephrotoxicity of Dx (measured as creatinine level), possessed moderate immunomodulating activity (as revealed by an increase in number of cytotoxic T-lymphocytes), and partially increased survival of NK/Ly lymphoma-bearing animals treated with Dx. On the contrary, there was little tissue-protective effect of NAC towards LA due to the weak side effects of this anticancer drug, however, the combined use of NAC and LA significantly increased survival (60+ days) of LA-treated animals with NK/Ly lymphoma. Summarizing, NAC possesses a moderate tissue-protective activity towards Dx action but lacks a major therapeutic effect. However, in the case of LA action, NAC significantly increases its anticancer activity with no impact on its negative side effects. Further studies of the molecular mechanisms underlying that activity of NAC towards the action of LA are in progress.
first_indexed 2024-03-09T07:29:51Z
format Article
id doaj.art-0ff15cce1342428982f60aa823e8581b
institution Directory Open Access Journal
issn 2409-4943
2413-5003
language English
last_indexed 2024-03-09T07:29:51Z
publishDate 2018-04-01
publisher National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry
record_format Article
series The Ukrainian Biochemical Journal
spelling doaj.art-0ff15cce1342428982f60aa823e8581b2023-12-03T06:26:47ZengNational Academy of Sciences of Ukraine, Palladin Institute of BiochemistryThe Ukrainian Biochemical Journal2409-49432413-50032018-04-01902465410.15407/ubj90.02.046Impact of N-acetylcysteine on antitumor activity of doxorubicin and landomycin A in NK/Ly lymphoma-bearing miceYu. S. Kozak0R. R. Panchuk1N. R. Skorokhyd2L. V. Lehka3R. S. Stoika4Ivan Franko National University of Lviv, UkraineІnstitute of Cell Biology, National Academy of Sciences of Ukraine, LvivІnstitute of Cell Biology, National Academy of Sciences of Ukraine, LvivІnstitute of Cell Biology, National Academy of Sciences of Ukraine, LvivIvan Franko National University of Lviv, Ukraine; Іnstitute of Cell Biology, National Academy of Sciences of Ukraine, Lviv N-acetylcysteine (NAC) is a dietary supplement demonstrating antioxidant and liver protecting effects that is widely used in clinics. NAC is considered to possess potential therapeutic activity for health disorders characterized by generation of free oxygen radicals, as well as potential for decreasing negative side effects of various drugs. However, the mechanisms of such tissue-protective actions of NAC remain poorly understood. The main aim of this work was to study therapeutic effects of NAC applied together with the “gold standard” of chemotherapy doxorubicin (Dx) or the novel experimental drug landomycin A (LA) to mice bearing NK/Ly lymphoma. It was revealed that NAC significantly decreased the nephrotoxicity of Dx (measured as creatinine level), possessed moderate immunomodulating activity (as revealed by an increase in number of cytotoxic T-lymphocytes), and partially increased survival of NK/Ly lymphoma-bearing animals treated with Dx. On the contrary, there was little tissue-protective effect of NAC towards LA due to the weak side effects of this anticancer drug, however, the combined use of NAC and LA significantly increased survival (60+ days) of LA-treated animals with NK/Ly lymphoma. Summarizing, NAC possesses a moderate tissue-protective activity towards Dx action but lacks a major therapeutic effect. However, in the case of LA action, NAC significantly increases its anticancer activity with no impact on its negative side effects. Further studies of the molecular mechanisms underlying that activity of NAC towards the action of LA are in progress.http://ukrbiochemjournal.org/wp-content/uploads/2018/03/Kozak_2_18.pdfdoxorubicinlandomycin AN-acetylcysteineNK/Ly lymphoma
spellingShingle Yu. S. Kozak
R. R. Panchuk
N. R. Skorokhyd
L. V. Lehka
R. S. Stoika
Impact of N-acetylcysteine on antitumor activity of doxorubicin and landomycin A in NK/Ly lymphoma-bearing mice
The Ukrainian Biochemical Journal
doxorubicin
landomycin A
N-acetylcysteine
NK/Ly lymphoma
title Impact of N-acetylcysteine on antitumor activity of doxorubicin and landomycin A in NK/Ly lymphoma-bearing mice
title_full Impact of N-acetylcysteine on antitumor activity of doxorubicin and landomycin A in NK/Ly lymphoma-bearing mice
title_fullStr Impact of N-acetylcysteine on antitumor activity of doxorubicin and landomycin A in NK/Ly lymphoma-bearing mice
title_full_unstemmed Impact of N-acetylcysteine on antitumor activity of doxorubicin and landomycin A in NK/Ly lymphoma-bearing mice
title_short Impact of N-acetylcysteine on antitumor activity of doxorubicin and landomycin A in NK/Ly lymphoma-bearing mice
title_sort impact of n acetylcysteine on antitumor activity of doxorubicin and landomycin a in nk ly lymphoma bearing mice
topic doxorubicin
landomycin A
N-acetylcysteine
NK/Ly lymphoma
url http://ukrbiochemjournal.org/wp-content/uploads/2018/03/Kozak_2_18.pdf
work_keys_str_mv AT yuskozak impactofnacetylcysteineonantitumoractivityofdoxorubicinandlandomycinainnklylymphomabearingmice
AT rrpanchuk impactofnacetylcysteineonantitumoractivityofdoxorubicinandlandomycinainnklylymphomabearingmice
AT nrskorokhyd impactofnacetylcysteineonantitumoractivityofdoxorubicinandlandomycinainnklylymphomabearingmice
AT lvlehka impactofnacetylcysteineonantitumoractivityofdoxorubicinandlandomycinainnklylymphomabearingmice
AT rsstoika impactofnacetylcysteineonantitumoractivityofdoxorubicinandlandomycinainnklylymphomabearingmice